Literature DB >> 36056221

Predictors of high-degree atrioventricular block in patients with new-onset left bundle branch block following transcatheter aortic valve replacement.

Nashwa M Abdulsalam1, Jeanne E Poole2, Elizabeth R Lyden3, Arthur J Easley3, Gregory S Pavlides3, Shane F Tsai3, David E Barton4.   

Abstract

BACKGROUND: The development of new left bundle branch block (LBBB) is frequently seen post TAVR and is a known risk factor for progression to high degree AV block. The timing and likelihood of progression into complete heart block is variable and can develop after hospital discharge. We sought to determine predictors for the development of high degree AV block in patients who developed LBBB following TAVR.
METHODS: All patients between 2014 and 2019 underwent electrophysiology study after developing LBBB post TAVR. Data on these patients including baseline characteristics, echo parameters, EKG variables, HV interval, and the need for subsequent pacemaker implantation were extracted. A prolonged HV interval was defined as ≥ 65 ms. Clinically significant conduction abnormality was defined as development of high-degree AV block or clinically significant complete heart block.
RESULTS: Thirty-four patients were included in our study of which 10 (29.4%) developed clinically significant heart block, while 24 (70.6%) did not. The mean HV interval for patients with clinically significant heart block was 70.1 ms vs 57.8 ms for those who did not (p = 0.022). Pre-existing first-degree heart block prior to TAVR (p = 0.026), history of AFib (p = 0.05) in addition to STS score (p = 0.037) were predictors of development of high-degree AV block in our patient population.
CONCLUSIONS: In patients who develop LBBB following TAVR, HV interval, pre-existing first-degree heart block, and STS score predict progression to high-degree AV block. Performance of a routine electrophysiology study should be considered for high-risk patients who develop LBBB following TAVR.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Electrophysiology study; Heart block; LBBB; TAVR

Year:  2022        PMID: 36056221     DOI: 10.1007/s10840-022-01361-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  14 in total

1.  Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death.

Authors:  Marina Urena; John G Webb; Helene Eltchaninoff; Antonio J Muñoz-García; Claire Bouleti; Corrado Tamburino; Luis Nombela-Franco; Fabian Nietlispach; Cesar Moris; Marc Ruel; Antonio E Dager; Vicenç Serra; Asim N Cheema; Ignacio J Amat-Santos; Fabio Sandoli de Brito; Pedro Alves Lemos; Alexandre Abizaid; Rogério Sarmento-Leite; Henrique B Ribeiro; Eric Dumont; Marco Barbanti; Eric Durand; Juan H Alonso Briales; Dominique Himbert; Alec Vahanian; Sebastien Immè; Eulogio Garcia; Francesco Maisano; Raquel del Valle; Luis Miguel Benitez; Bruno García del Blanco; Hipólito Gutiérrez; Marco Antonio Perin; Dimytri Siqueira; Guilherme Bernardi; François Philippon; Josep Rodés-Cabau
Journal:  J Am Coll Cardiol       Date:  2015-02-10       Impact factor: 24.094

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Coletta Barrett; James R Edgerton; Kenneth A Ellenbogen; Michael R Gold; Nora F Goldschlager; Robert M Hamilton; José A Joglar; Robert J Kim; Richard Lee; Joseph E Marine; Christopher J McLeod; Keith R Oken; Kristen K Patton; Cara N Pellegrini; Kimberly A Selzman; Annemarie Thompson; Paul D Varosy
Journal:  Circulation       Date:  2018-11-06       Impact factor: 29.690

4.  Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.

Authors:  Jeffrey J Popma; G Michael Deeb; Steven J Yakubov; Mubashir Mumtaz; Hemal Gada; Daniel O'Hair; Tanvir Bajwa; John C Heiser; William Merhi; Neal S Kleiman; Judah Askew; Paul Sorajja; Joshua Rovin; Stanley J Chetcuti; David H Adams; Paul S Teirstein; George L Zorn; John K Forrest; Didier Tchétché; Jon Resar; Antony Walton; Nicolo Piazza; Basel Ramlawi; Newell Robinson; George Petrossian; Thomas G Gleason; Jae K Oh; Michael J Boulware; Hongyan Qiao; Andrew S Mugglin; Michael J Reardon
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

5.  Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.

Authors:  Michael J Mack; Martin B Leon; Vinod H Thourani; Raj Makkar; Susheel K Kodali; Mark Russo; Samir R Kapadia; S Chris Malaisrie; David J Cohen; Philippe Pibarot; Jonathon Leipsic; Rebecca T Hahn; Philipp Blanke; Mathew R Williams; James M McCabe; David L Brown; Vasilis Babaliaros; Scott Goldman; Wilson Y Szeto; Philippe Genereux; Ashish Pershad; Stuart J Pocock; Maria C Alu; John G Webb; Craig R Smith
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

6.  Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.

Authors:  Raj R Makkar; Gregory P Fontana; Hasan Jilaihawi; Samir Kapadia; Augusto D Pichard; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; John G Webb; Howard C Herrmann; Joseph E Bavaria; Susheel Kodali; David L Brown; Bruce Bowers; Todd M Dewey; Lars G Svensson; Murat Tuzcu; Jeffrey W Moses; Matthew R Williams; Robert J Siegel; Jodi J Akin; William N Anderson; Stuart Pocock; Craig R Smith; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

7.  Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review.

Authors:  Philippe J van Rosendael; Victoria Delgado; Jeroen J Bax
Journal:  Eur Heart J       Date:  2018-06-01       Impact factor: 29.983

8.  Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

Review 9.  Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.

Authors:  Vincent Auffret; Rishi Puri; Marina Urena; Chekrallah Chamandi; Tania Rodriguez-Gabella; François Philippon; Josep Rodés-Cabau
Journal:  Circulation       Date:  2017-09-12       Impact factor: 29.690

10.  Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve.

Authors:  Nicolo Piazza; Yoshinobu Onuma; Emile Jesserun; Peter Paul Kint; Anne-Marie Maugenest; Robert H Anderson; Peter P Th de Jaegere; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2008-06       Impact factor: 11.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.